Pfizer Inc. (NYSE:PFE)

The financial data reveals a cyclical profitability pattern characterized by a period of strong performance, a significant contraction into negative territory, and a subsequent recovery followed by a gradual decline in net returns.

Gross Profit Margin

A volatile but generally upward trajectory is observed in gross profitability. After reaching a peak of 69.61% in July 2023, a sharp decline occurred, hitting a low of 58.09% by March 2024. However, a robust recovery followed, with margins climbing to a peak of 74.33% in December 2025 and stabilizing above 73% through June 2026.

Operating and Net Profit Margins

Both metrics exhibit a severe downturn between July 2023 and June 2024. Operating profit margins plummeted from 28.13% to a low of -4.19%, while net profit margins dropped from 27.38% to -4.62% in the same window. A strong V-shaped recovery is evident starting in September 2024, with operating margins returning to a peak of 23.23% in June 2025. Notably, while operating margins remained relatively stable in the final periods, net profit margins showed a steady decline from 16.84% in June 2025 to 6.80% by June 2026.

Return on Equity (ROE) and Return on Assets (ROA)

Efficiency ratios mirrored the trend of the profit margins. ROE fell from initial levels above 30% to a trough of -2.96% in June 2024, later recovering to 12.12% in June 2025. Similarly, ROA declined from a high of 15.91% in December 2022 to -1.20% in June 2024, recovering to a peak of 5.22% in June 2025. Both ratios entered a gradual downward trend in the final year, with ROE ending at 5.09% and ROA at 2.15% by June 2026.

The divergence observed in the final quarters is significant: while gross profit margins remained at historical highs, net profit margins, ROE, and ROA all trended downward. This suggests that while the core product profitability remained strong, increasing operating expenses, taxes, or other non-operating costs began to erode the final bottom-line returns and capital efficiency.

The gross profit margin exhibits a cyclical pattern characterized by an initial period of expansion, a sharp contraction in late 2023 and early 2024, and a subsequent sustained recovery reaching peak levels by late 2025.

Initial Margin Expansion (April 2022 – July 2023)

A consistent upward trend in profitability is observed during this period, with the gross profit margin increasing from 60.35% to a peak of 69.61%. This growth occurred despite a general decline in total revenues, which fell from a high of 27,742 million USD in July 2022 to 13,007 million USD by July 2023, suggesting improved cost efficiencies or a shift in product mix.

Period of Margin Compression (October 2023 – March 2024)

A significant downturn occurred starting in October 2023, where the margin dropped sharply to 60.97% and continued to decline to a trough of 58.09% by March 2024. This period coincides with a substantial dip in gross profit, which reached its lowest point of 4,223 million USD in October 2023.

Recovery and Peak Profitability (June 2024 – December 2025)

Starting in June 2024, a strong recovery phase is evident. The gross profit margin climbed steadily from 58.18% to a maximum of 74.33% by December 2025. This phase is marked by a positive correlation between revenue growth and margin expansion, as revenues recovered to 17,557 million USD by the end of 2025.

Stabilization Phase (March 2026 – June 2026)

The most recent data indicates a period of stabilization. The gross profit margin experienced a slight moderation, moving from 73.51% in March 2026 to 73.18% in June 2026, suggesting that profitability has reached a plateau at a significantly higher baseline than that observed in 2022.

The operational profitability exhibits a distinct cyclical trajectory, transitioning from a period of high expansion to a severe contraction, followed by a steady recovery and stabilization phase. The overall trend reflects a significant volatility in operating efficiency between early 2022 and mid-2024, eventually settling into a more sustainable margin range by 2025.

Operating Profit Margin Fluctuations

A period of peak efficiency was observed between April 2022 and April 2023, where the operating profit margin climbed from 26.12% to a peak of 34.83% in December 2022. This was followed by a precipitous decline throughout 2023 and the first half of 2024, with the margin falling into negative territory, reaching a trough of -4.19% by June 30, 2024.

A robust recovery began in the second half of 2024, as the margin surged to 9.56% in September and further increased to 19.51% by December 2024. From March 2025 through June 2026, the margin stabilized, consistently fluctuating within a narrower band between 21.70% and 23.23%.

Revenue and Operating Income Correlation

The decline in profitability margins coincided with a significant reduction in revenues, which dropped from a high of 27,742 million USD in July 2022 to lows between 13,007 million USD and 14,879 million USD during much of 2023 and early 2024. This revenue compression, paired with operating losses that peaked at -4,289 million USD in December 2023, drove the negative margin trend.

The subsequent recovery in the operating profit margin was achieved despite revenues remaining well below the 2022 peaks. For instance, while revenues in June 2026 stood at 15,034 million USD—significantly lower than the 2022 levels—the operating profit margin recovered to 21.70%, suggesting a realignment of the cost structure or a shift in product mix toward higher-margin offerings.

Long-term Operational Stability

The data indicates a transition from a high-growth, high-margin environment to a period of operational correction, and finally to a stabilized state. The consistency of the margin in 2025 and 2026 suggests that the operational volatility experienced during the 2023-2024 period has been mitigated, establishing a new baseline for profitability around the 22% mark.

The financial data reveals a period of significant volatility in profitability, characterized by an initial peak, a sharp contraction into negative territory, and a subsequent partial recovery followed by renewed instability.

Net Profit Margin Trends

A period of peak profitability is observed between April 2022 and April 2023, with margins consistently exceeding 27% and reaching a maximum of 31.27% in December 2022. This was followed by a rapid deterioration starting in July 2023, where margins fell from 27.38% to a low of -4.62% by June 2024. A recovery phase ensued in the latter half of 2024, with the margin climbing to 16.84% by June 2025. However, this recovery proved unstable, as margins trended downward again to 6.80% by June 2026.

Revenue and Net Income Correlation

Revenues peaked in July 2022 at 27,742 million US$ before experiencing a substantial decline, reaching a trough of 13,007 million US$ in July 2023. While revenues stabilized between 13,000 million and 17,000 million US$ from 2023 through 2026, net income exhibited much higher variance. Net income shifted from gains of nearly 10 billion US$ in mid-2022 to losses exceeding 3 billion US$ in December 2023, indicating a significant compression of margins that outpaced the decline in top-line revenue.

Profitability Volatility and Sustainability

The transition from high positive margins (31.27%) to negative margins (-4.62%) within an 18-month window suggests a period of severe operational or structural adjustment. Although the margin returned to positive figures in September 2024, the recurrence of negative net income in December 2025 and June 2026 highlights a lack of sustained profitability stability, ending the analyzed period with a margin significantly lower than the 2022 baseline.

The Return on Equity (ROE) exhibits a significant downward trajectory over the analyzed period, transitioning from a peak of high profitability in 2022 to a period of volatility and reduced returns through mid-2026. The trend is characterized by an initial phase of strong performance, a sharp contraction leading into negative territory, and a subsequent partial recovery that failed to reach previous highs.

Profitability Peak and Contraction

Between April 2022 and December 2022, ROE remained consistently high, peaking at 33.61% in July 2022. This performance was supported by strong net income figures, which exceeded 4.9 billion US$ in each quarter of that year. However, a steep decline began in early 2023, with ROE dropping from 28.77% in April to 2.38% by December 2023, mirroring a collapse in net income that turned negative in the second half of the year.

Period of Negative Returns and Volatility

The lowest point of profitability occurred in the first half of 2024, where ROE dipped into negative territory, reaching -2.96% by June 30, 2024. This coincided with a period of minimal or negative net income. A recovery phase followed in the latter half of 2024, with ROE climbing back to 9.11% by December 31, 2024, as net income returned to positive levels.

Equity Base and Return Stability

Total shareholders' equity showed a steady increase from 82.4 billion US$ in April 2022 to a peak of 100.9 billion US$ in April 2023. Following this peak, equity levels fluctuated between approximately 85 billion US$ and 93 billion US$. The expansion of the equity base during the initial period of declining net income accelerated the reduction of the ROE, as a larger capital base yielded diminishing returns.

Recent Performance Trends

From March 2025 through June 2026, ROE demonstrated moderate volatility, fluctuating between a high of 12.12% in June 2025 and a low of 5.09% in June 2026. The instability in these figures is directly linked to inconsistent quarterly net income, including a significant loss of 1.6 billion US$ in December 2025 and a further loss of 248 million US$ in June 2026.

The Return on Assets (ROA) exhibits a significant cyclical decline followed by a period of volatile stabilization between April 2022 and June 2026. The trajectory is characterized by a transition from high profitability to negative returns, followed by a partial recovery that remains substantially below the initial baseline.

Phase of Peak Asset Efficiency (April 2022 – December 2022)

A period of strong asset utilization is observed, with ROA increasing from 13.58% to a peak of 15.91%. This growth was driven by robust net income figures, which reached 9,906 million US$ in July 2022, while total assets remained relatively stable within the range of 183,841 million US$ to 197,205 million US$.

Phase of Contraction and Negative Returns (April 2023 – June 2024)

A sharp downward trend in ROA occurred, falling from 14.85% in April 2023 to a minimum of -1.20% by June 2024. This decline was the result of a simultaneous collapse in net income, which turned negative in the second half of 2023, and an expansion of the asset base, which peaked at 226,501 million US$ in December 2023. The increase in total assets during a period of net losses significantly accelerated the erosion of asset efficiency.

Phase of Volatile Stabilization (July 2024 – June 2026)

ROA entered a recovery phase, climbing to 5.22% by June 2025. However, this recovery was inconsistent, mirroring fluctuations in net income that alternated between positive gains and losses. Despite a reduction in total assets to 201,131 million US$ by June 2026, the ROA trended downward in the final quarters, ending at 2.15%. This indicates that while the company avoided sustained negative returns, it failed to recapture the high efficiency levels recorded in 2022.